Drug for Covid-19 Shows Some Early Promise

Eli Lilly claims its monoclonal antibody is lowering Covid-19 hospitalizations in trial

The drug company Eli Lilly released some early data on a drug they are studying for Covid-19 that’s called a monoclonal antibody. These are man-made antibodies — developed from the antibodies of someone who recovered from Covid-19 — that are used by the immune system to fight the virus. According to the data released by the company (note, not peer-reviewed) it appears the drug helped people sick with Covid-19…

--

--

--

A blog from Medium for Covid-19 news, advice, and commentary.

Recommended from Medium

COVID-19 Impacts on Long-Term Care Residents: A Patient-Initiated Research Project

A Thorough Guide for Pandemic Decision-Making

BC’s First Nations Tribes Are Showing us How to Beat Covid, It’s time to Listen.

Should You Get Travel Insurance for Your Upcoming Trip?

Should You Get Travel Insurance for Your Upcoming Trip?

Ontario COVID numbers: 1,122 people in hospital, 159 in intensive care

Weekly Coronavirus Update: Tuesday, December 22, 2020

Another grim Covid-19 milestone: At least 800,000 Americans have died

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Coronavirus Blog Team

Coronavirus Blog Team

A real-time resource for news, advice, and commentary brought to you by Medium.

More from Medium

The Real Thoughts in a Student Athlete’s Mind: Dealing with Stress and Depression

There is a wide variety of water and water filters available in Tenerife

Chaos, it’s All Chaos

We are nature , think positive it affects chemistry .